France’s Sanofi announces positive update for mRNA-based COVID-19 vaccine candidate

PARIS — French healthcare company Sanofi announced on Tuesday positive Phase I/II study interim results for its first mRNA-based COVID-19 vaccine candidate.

Sanofi said initial data from these results showed neutralizing antibody seroconversion in 91%-100% of study participants, two weeks after a second injection, across all three dosages tested.

“These results will clearly help inform the path forward for our mRNA development programs,” said Jean-Francois Toussaint, global head of research and development at Sanofi Pasteur.

Sanofi added that these results showed the potential behind the Translate Bio company recently acquired by Sanofi.

Sanofi is under pressure to revive its drug pipeline and is also eager to overcome setbacks in the COVID-19 vaccine race.

(Reporting by Sudip Kar-Gupta, editing by Louise Heavens)

Football news:

Nicola Amoruso: Under Spalletti, Napoli became an adult team. De Laurentiis can count on the championship this year
Mourinho is one of the candidates for the post of Newcastle coach. The Saudis believe that he will improve the image of the club
Sulscher on Rashford's social activities: Now he should prioritize football
The Prince of Cambodia refused to acquire Saint-Etienne
Dani Alves: If Barcelona thinks they need me, it's a matter of one call. I can still be useful
Lewandowski wants to move to Real Madrid. He will ask Bayern for a transfer (As)
Sarri about the calendar: Football is no longer a sport, but a show from which they are trying to squeeze as much money as possible